Consumption of Yoghurt and Other Dairy Products and Risk of Colorectal Cancer in Iran: The IROPICAN Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
16 Jun 2022
Historique:
received: 18 05 2022
revised: 02 06 2022
accepted: 08 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

There is evidence of an inverse association between yoghurt intake and risk of colorectal cancer (CRC). We aimed at investigating the association between the intake of yoghurt and other dairy foods consumed in Iran and CRC risk. Our analysis included 4070 subjects within the IROPICAN (Iran Study of Opium and Cancer) study. Detailed information was collected by the use of validated questionnaires. We estimated adjusted odds ratios (OR) and 95% confidence intervals (CI) for the association between the intake of total dairy products, and, separately, of yoghurt, milk, cheese, kashk, dough, cream, ice cream, and other milk products, and CRC using unconditional logistic regression analyses. The intake was categorized in tertiles. Overall, we analyzed 865 cases and 3205 controls. Total dairy products intake was not associated with CRC. The OR for one tertile increase (OR_T) in yoghurt intake was 0.97 (95% CI 0.87-1.08) for CRC and 0.66 (95% CI 0.52-0.84) for proximal colon cancer. Cream intake was associated with CRC (OR_T3 = 1.33, 95% CI 1.08-1.64), colon (OR_T3 = 1.37, 95% CI 1.03-1.81), and proximal cancer (OR_T3 = 1.29, 95% CI 1.04-1.61). The OR of distal colon cancer for ice cream intake was 0.59 (95% CI 0.43-0.82). Other dairy products were not associated with CRC risk.

Sections du résumé

BACKGROUND BACKGROUND
There is evidence of an inverse association between yoghurt intake and risk of colorectal cancer (CRC). We aimed at investigating the association between the intake of yoghurt and other dairy foods consumed in Iran and CRC risk.
METHODS METHODS
Our analysis included 4070 subjects within the IROPICAN (Iran Study of Opium and Cancer) study. Detailed information was collected by the use of validated questionnaires. We estimated adjusted odds ratios (OR) and 95% confidence intervals (CI) for the association between the intake of total dairy products, and, separately, of yoghurt, milk, cheese, kashk, dough, cream, ice cream, and other milk products, and CRC using unconditional logistic regression analyses. The intake was categorized in tertiles.
RESULTS RESULTS
Overall, we analyzed 865 cases and 3205 controls. Total dairy products intake was not associated with CRC. The OR for one tertile increase (OR_T) in yoghurt intake was 0.97 (95% CI 0.87-1.08) for CRC and 0.66 (95% CI 0.52-0.84) for proximal colon cancer. Cream intake was associated with CRC (OR_T3 = 1.33, 95% CI 1.08-1.64), colon (OR_T3 = 1.37, 95% CI 1.03-1.81), and proximal cancer (OR_T3 = 1.29, 95% CI 1.04-1.61). The OR of distal colon cancer for ice cream intake was 0.59 (95% CI 0.43-0.82). Other dairy products were not associated with CRC risk.

Identifiants

pubmed: 35745234
pii: nu14122506
doi: 10.3390/nu14122506
pmc: PMC9228368
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Institute of Medical Research Development (NIMAD) (Code: IR.NIMAD.REC.1394.027).
ID : IR.NIMAD.REC.1394.027

Références

Ann Oncol. 2017 Aug 01;28(8):1788-1802
pubmed: 28407090
BMC Microbiol. 2015 Nov 11;15:261
pubmed: 26560346
Lipids Health Dis. 2019 Feb 4;18(1):41
pubmed: 30717735
J Food Sci Technol. 2022 Mar;59(3):1063-1074
pubmed: 35185209
Arch Iran Med. 2019 Jul 01;22(7):369-375
pubmed: 31679379
Arch Iran Med. 2021 Mar 01;24(3):167-176
pubmed: 33878874
Benef Microbes. 2016 Sep;7(4):473-84
pubmed: 27133564
Int J Cancer. 2018 Sep 15;143(6):1356-1366
pubmed: 29663376
Folia Microbiol (Praha). 2020 Feb;65(1):17-24
pubmed: 31001762
Nutrients. 2020 Mar 23;12(3):
pubmed: 32210128
Biomarkers. 2019 Jun;24(4):360-372
pubmed: 30773031
Mol Nutr Food Res. 2020 Nov;64(21):e2000319
pubmed: 32844586
Gastroenterology. 2021 Mar;160(4):1041-1049
pubmed: 33417940
Food Chem Toxicol. 2009 Aug;47(8):1872-5
pubmed: 19426778
Crit Rev Food Sci Nutr. 2020;60(20):3387-3399
pubmed: 31729242
Iran J Public Health. 2014 Aug;43(8):1139-44
pubmed: 25927044
Cancer Epidemiol. 2019 Aug;61:50-58
pubmed: 31132560
Asian Pac J Cancer Prev. 2015;16(9):3991-5
pubmed: 25987074
Am J Clin Nutr. 2005 Oct;82(4):894-900
pubmed: 16210722
Cell Host Microbe. 2019 Sep 11;26(3):314-324
pubmed: 31513770
Lancet. 2019 Oct 19;394(10207):1467-1480
pubmed: 31631858
Nutrients. 2021 Oct 13;13(10):
pubmed: 34684583
Eur J Nutr. 2020 Apr;59(3):953-963
pubmed: 30929068
Nutrients. 2020 Jun 28;12(7):
pubmed: 32605287
Curr Dev Nutr. 2019 Sep 19;3(9):nzz098
pubmed: 31556409
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Front Oncol. 2021 Nov 01;11:705927
pubmed: 34804915
Front Oncol. 2021 Sep 14;11:650026
pubmed: 34595105
Front Microbiol. 2021 Sep 28;12:727937
pubmed: 34650531
J Nutr. 2021 Nov 2;151(11):3400-3412
pubmed: 34386821
Am J Epidemiol. 2018 Apr 1;187(4):647-655
pubmed: 29145581
Am J Clin Nutr. 2020 Dec 10;112(6):1566-1575
pubmed: 33022694
Eur J Cancer Prev. 2017 May;26(3):201-211
pubmed: 26945285
FAO Food Nutr Pap. 1982;26:1-265
pubmed: 6311611
Nutr Rev. 2018 Dec 1;76(Suppl 1):4-15
pubmed: 30452699
Biomolecules. 2019 Oct 01;9(10):
pubmed: 31581581
Food Res Int. 2021 Jan;139:109972
pubmed: 33509518
Nat Rev Clin Oncol. 2021 Apr;18(4):230-243
pubmed: 33219329
Food Chem. 2021 May 15;344:128573
pubmed: 33199117
Nutr Rev. 2019 Jan 1;77(1):46-63
pubmed: 30307550
Rev Environ Health. 2021 May 14;37(1):123-135
pubmed: 33984875
Eur J Cancer Prev. 2020 May;29(3):201-209
pubmed: 28683007
Am J Clin Nutr. 2016 Jan;103(1):3-4
pubmed: 26675769
Nutr Rev. 2018 Dec 1;76(Suppl 1):29-39
pubmed: 30452698
Food Res Int. 2020 Jun;132:109107
pubmed: 32331649
PLoS One. 2017 Aug 30;12(8):e0183017
pubmed: 28854228
Front Nutr. 2022 Jan 03;8:789006
pubmed: 35047546
Nutr Res Pract. 2021 Aug;15(4):411-430
pubmed: 34349876
Nutr Cancer. 1989;12(4):351-9
pubmed: 2608540
J Oncol. 2021 May 25;2021:9948814
pubmed: 34122548
Public Health Nutr. 2013 May;16(5):928-35
pubmed: 22874008
Eur J Clin Nutr. 2003 Jan;57(1):1-17
pubmed: 12548291

Auteurs

Giulia Collatuzzo (G)

Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.

Monireh Sadat Seyyedsalehi (MS)

Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran 1416634793, Iran.

Abbas Rezaeianzadeh (A)

Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz 7146864685, Iran.

Maryam Marzban (M)

Department of Public Health, School of Public Health, Bushehr University of Medical Science, Bushehr 7514763448, Iran.
Clinical Research Development Center, The Persian Gulf Martyrs, Bushehr University of Medical Science, Bushehr 7514763448, Iran.

Hamideh Rashidian (H)

Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran 1416634793, Iran.

Maryam Hadji (M)

Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran 1416634793, Iran.
Health Sciences Unit, Faculty of Social Sciences, Tampere University, 33100 Tampere, Finland.

Farin Kamangar (F)

Department of Biology, School of Computer, Mathematical, and Natural Sciences, Morgan State University, Baltimore, MD 21251, USA.

Arash Etemadi (A)

Digestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran 1416634793, Iran.
Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20810, USA.

Eero Pukkala (E)

Health Sciences Unit, Faculty of Social Sciences, Tampere University, 33100 Tampere, Finland.
Finnish Cancer Registry-Institute for Statistical and Epidemiological Cancer Research, 00100 Helsinki, Finland.

Kazem Zendehdel (K)

Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran 1416634793, Iran.

Paolo Boffetta (P)

Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH